Research Topics
Species | Hudson FreezeSummaryAffiliation: The Burnham Institute Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Balancing N-linked glycosylation to avoid diseaseH H Freeze
The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA
Biochimie 83:791-9. 2001..By assessing the occurrence of a series of N-glycosylation-compromising alleles in multi-genic diseases, it may be possible to determine whether impaired glycosylation is a risk factor or a major determinant underlying their pathology...
Altered glycan structures: the molecular basis of congenital disorders of glycosylationHudson H Freeze
The Burnham Institute, Glycobiology and Carbohydrate Chemistry Program, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA
Curr Opin Struct Biol 15:490-8. 2005..Although most of the deficiencies observed in CDG patients are only partial, the severity of the clinical manifestations signifies the relevance of protein N-glycosylation and shows the importance of defined glycan structures...
Metabolic manipulation of glycosylation disorders in humans and animal modelsHudson H Freeze
Sanford Burnham Medical Research Institute, La Jolla, CA 92037, USA
Semin Cell Dev Biol 21:655-62. 2010..This metabolic perspective may help explain some of these observations and guide the development of other vertebrate models of glycosylation disorders that can respond to dietary manipulation...
Congenital Disorders of Glycosylation: CDG-I, CDG-II, and beyondHudson H Freeze
Glycobiology and Carbohydrate Chemistry Program, Burnham Institute for Medical Research, 10901 N Torrey Pines Rd, La Jolla, CA, 92037, USA
Curr Mol Med 7:389-96. 2007..This surprising finding makes identifying their defects more challenging, but the defects and associated clinical manifestations of these patients suggest that the N-glycosylation pathway has some secrets left to share...
Genetic defects in the human glycomeHudson H Freeze
Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, California 92037, USA
Nat Rev Genet 7:537-51. 2006..As more glycosylation disorders and patients with these disorders are identified, the functions of the glycome are starting to be revealed...
Human disorders in N-glycosylation and animal modelsHudson H Freeze
Glycobiology and Carbohydrate Chemistry Program, The Burnham Institute, La Jolla, CA 92037, USA
Biochim Biophys Acta 1573:388-93. 2002..Investigators designing model systems to study human glycosylation disorders may want to construct strains with several heterozygous hypomorphic alleles in rate-limiting steps in the glycosylation pathway...
Sweet solution: sugars to the rescueHudson H Freeze
The Burnham Institute, La Jolla Cancer Research Center, 10901 N Torrey Pines Road, La Jolla, CA 92037, USA
J Cell Biol 158:615-6. 2002..2002, this issue) use one to rescue designer mice unable to make GDP-Fucose. Dietary fucose enters a salvage pathway and spares the mice. Sound simple? Not so. Unknown genetic factors determine life or death...
Congenital disorders of glycosylation and the pediatric liverH H Freeze
Glycobiology and Carbohydrate Chemistry Program, The Burnham Institute, La Jolla, California 92037, USA
Semin Liver Dis 21:501-15. 2001....
N -Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowthGeetha Srikrishna
The Burnham Institute, La Jolla, California 92037, USA
J Neurochem 80:998-1008. 2002..These results indicate that carboxylated N -glycans on RAGE play an important functional role in amphoterin-RAGE-mediated signalling...
Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patientsHudson H Freeze
Sanford Children s Health Research Center, Burnham Institute for Medical Research, 10901 N Torrey Pines Rd, La Jolla, CA 92037, USA
Biochim Biophys Acta 1792:835-40. 2009..Glycosylation-deficient cell and animal models are needed to determine which individual or combined approaches improve glycosylation and may be suitable for preclinical evaluation...
Intracranial hemorrhage as the initial manifestation of a congenital disorder of glycosylationRonald D Cohn
McKusick Nathans Institute of Genetic Medicine, Johns Hopkins Hospital, Children s Center, Johns Hopkins University School of Medicine, 600 N Wolfe St, Blalock 1008, Baltimore, Maryland 21205, USA
Pediatrics 118:e514-21. 2006..Intracranial hemorrhage in a term neonate without a potential precipitating factor represents yet another clinical feature that should raise the suspicion for a congenital disorder of glycosylation...
Carboxylated glycans mediate colitis through activation of NF-kappa BGeetha Srikrishna
Glycobiology Program, The Burnham Institute, La Jolla, CA 92037, USA
J Immunol 175:5412-22. 2005..It specifically blocked activation of NF-kappaB p65 in lamina propria cells of colitic mice and in activated macrophages. These results indicate that carboxylate-glycan-dependent pathways contribute to the early onset of colitis...
Ablation of mouse phosphomannose isomerase (Mpi) causes mannose 6-phosphate accumulation, toxicity, and embryonic lethalityCharles DeRossi
Glycobiology and Carbohydrate Chemistry Program, Burnham Institute for Medical Research, 10901 N Torrey Pines Road, La Jolla, CA 92037, USA
J Biol Chem 281:5916-27. 2006..5 Mpi(-/-) embryos where Man-6-P increased more than 10 times, and ATP decreased by 50% compared with Mpi(+/+) littermates. Because Mpi ablation is embryonic lethal, a murine CDG-Ib model will require hypomorphic Mpi alleles...
Novel perspectives on glycosylation and human diseaseHudson H Freeze
Curr Mol Med 7:387. 2007
Agm1/Pgm3-mediated sugar nucleotide synthesis is essential for hematopoiesis and developmentKylie T Greig
Division of Molecular Medicine, The Walter and Eliza Hall Institute of Medical Research, Victoria, Australia
Mol Cell Biol 27:5849-59. 2007....
Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorderXiaohua Wu
The Burnham Institute, 10901 N Torrey Pines Road, La Jolla, California 92037, USA
Nat Med 10:518-23. 2004..These cases represent a new type of CDG in which the molecular defect lies in a protein that affects the trafficking and function of the glycosylation machinery...
Cryptogenic liver disease in four children: a novel congenital disorder of glycosylationClaudia Mandato
Department of Pediatrics, University of Naples Federico II, Italy
Pediatr Res 59:293-8. 2006..Clinicians are encouraged to test such patients for abnormal Tf glycosylation by ESI-MS...
COG8 deficiency causes new congenital disorder of glycosylation type IIhChristian Kranz
Burnham Institute for Medical Research, La Jolla, CA 92037, USA
Hum Mol Genet 16:731-41. 2007..Lentiviral-mediated complementation with normal COG8 corrected mislocalization of other COG proteins, normalized sialylation and restored normal BFA-induced Golgi disruption. We propose to call this new disorder CDG-IIh or CDG-II/COG8...
Deficiency of UDP-GlcNAc:Dolichol Phosphate N-Acetylglucosamine-1 Phosphate Transferase (DPAGT1) causes a novel congenital disorder of Glycosylation Type IjXiaohua Wu
The Burnham Institute, La Jolla, California, USA
Hum Mutat 22:144-50. 2003..Thus, we conclude that the DPAGT1 gene defects are responsible for the CDG symptoms in this patient. Hum Mutat 22:144-150, 2003...
New disorders in carbohydrate metabolism: congenital disorders of glycosylation and their impact on the endocrine systemBradley S Miller
Division of Pediatric Endocrinology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, USA
Rev Endocr Metab Disord 4:103-13. 2003
RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesisOlga Turovskaya
Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA
Carcinogenesis 29:2035-43. 2008..These findings show that RAGE, carboxylated glycans and S100A8/A9 play essential roles in tumor-stromal interactions, leading to inflammation-associated colon carcinogenesis...
Molecular and clinical characterization of a Moroccan Cog7 deficient patientBobby G Ng
Department of Glycobiology and Carbohydrate Chemistry, Burnham Institute for Medical Research, La Jolla, CA 92037, USA
Mol Genet Metab 91:201-4. 2007..The mutation disrupted the hetero-octomeric COG complex and altered both N- and O-linked glycosylation. Here we present clinical and biochemical data from a second family with the same mutation...
Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethalityChristian Kranz
Burnham Institute for Medical Research, La Jolla, California, USA
Am J Med Genet A 143:1371-8. 2007..Congenital disorders of glycosylation should be considered for children with undiagnosed multi-system disease including neurodevelopmental delay, skeletal dysplasia, immune deficiency, male genital hypoplasia, and cardiomyopathy...
The relative contribution of mannose salvage pathways to glycosylation in PMI-deficient mouse embryonic fibroblast cellsNaonobu Fujita
Department of Applied Biological Science, Tokyo University of Agriculture and Technology, Japan
FEBS J 275:788-98. 2008..From these data, we conclude that PMI-null cells can salvage mannose from both endogenous and external glycoconjugates via lysosomal and nonlysosomal degradation pathways...
CDG-Id in two siblings with partially different phenotypesChristian Kranz
Glycobiology and Carbohydrate Chemistry Program, The Burnham Institute for Medical Research, 10901 N Torrey Pines Road, La Jolla, CA 92037, USA
Am J Med Genet A 143:1414-20. 2007..The defect is corrected by introduction of a normal ALG3 cDNA. CDG should be ruled out in all patients with severe seizures and failure to thrive. (c) 2007 Wiley-Liss, Inc...
Cloning and characterization of glucose transporter 11, a novel sugar transporter that is alternatively spliced in various tissuesXiaohua Wu
The Burnham Institute, La Jolla, CA 92037, USA
Mol Genet Metab 76:37-45. 2002..Furthermore, a liposome reconstitution functional assay showed that GLUT11-L has glucose transport activity...
Endoglycosidase and glycoamidase release of N-linked oligosaccharidesHudson H Freeze
The Burnham Institute, La Jolla, California, USA
Curr Protoc Protein Sci . 2006..These changes can be used to indicate when a protein has passed a particular subcellular location. This unit details some of the methods used to track a protein as it traffics from the ER to the Golgi toward its final location...
Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cellsJoseph N Contessa
Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA
Cancer Res 68:3803-9. 2008..This study provides evidence that enzymatic steps regulating N-linked glycosylation are novel targets for developing approaches to sensitize tumor cells to cytotoxic therapies...
Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier functionLars Bode
Burnham Institute for Medical Research, La Jolla, California 92037, USA
J Clin Invest 118:229-38. 2008..We demonstrate here that non-anticoagulant 2,3-de-O-sulfated heparin could prevent intestinal protein leakage in syndecan-deficient mice, suggesting that this may be a safe and effective therapy for PLE patients...
Essentials of glycosylationErik A Eklund
The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA
Semin Pediatr Neurol 12:134-43. 2005
The congenital disorders of glycosylation: a multifaceted group of syndromesErik A Eklund
Department of Cell and Molecular Biology, Lund University, Lund, Sweden
NeuroRx 3:254-63. 2006..In this review we will discuss the individual syndromes, with focus on their neuronal involvement, available and possible treatments, and future directions...
Molecular cloning, gene organization, and expression of mouse Mpi encoding phosphomannose isomeraseJoseph A Davis
Glycobiology Program, The Burnham Institute, 10901 North Torrey Pines Rd, La Jolla, CA 92037, USA
Glycobiology 12:435-42. 2002....
Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic originsGregory M Enns
Division of Medical Genetics, Department of Pediatrics, Stanford University, Palo Alto, California 94305, USA
J Pediatr 141:695-700. 2002..Screening for CDG should be considered in children with relatively mild neurologic impairment, especially if they have suggestive findings such as cerebellar hypoplasia and abnormal fat distribution...
GLUT14, a duplicon of GLUT3, is specifically expressed in testis as alternative splice formsXiaohua Wu
The Burnham Institute, La Jolla, California 92037, USA
Genomics 80:553-7. 2002..Interestingly, the ortholog of GLUT14 is not found in mice. The multiple duplications of GLUT genes suggest that the GLUT family probably emerged by gene duplications and mutations during evolution in different lineages...
Affinity capture and elution/electrospray ionization mass spectrometry assay of phosphomannomutase and phosphomannose isomerase for the multiplex analysis of congenital disorders of glycosylation types Ia and IbYijun Li
Department of Chemistry, University of Washington, Seattle, Washington 98195, USA
Anal Chem 75:42-8. 2003..The affinity purification procedure is fully automated, and the mass spectrometric analysis is multiplexed in a fashion that is suitable for high-throughput applications...
Identification of a frequent variant in ALG6, the cause of Congenital Disorder of Glycosylation-IcVibeke Westphal
The Burnham Institute, 10901 N Torrey Pines Rd, La Jolla, California 92037, USA
Hum Mutat 22:420-1. 2003..Thus, it is unclear whether c.391T>C causes CDG-Ic or contributes to the symptoms. Genotyping additional patients with CDG-like symptoms will be required to resolve this issue...
Testing for congenital disorders of glycosylation by HPLC measurement of serum transferrin glycoformsAnders Helander
Department of Clinical Neuroscience, Karolinska Institutet and University Hospital, Stockholm, Sweden
Clin Chem 50:954-8. 2004
Molecular and clinical description of the first US patients with congenital disorder of glycosylation IgErik A Eklund
The Burnham Institute, Glycobiology and Carbohydrate Chemistry Program, La Jolla, CA 92037, USA
Mol Genet Metab 84:25-31. 2005..We therefore conclude that a combination of developmental delay, low IgG, and genital hypoplasia should prompt CDG testing...
Congenital disorder of glycosylation id presenting with hyperinsulinemic hypoglycemia and islet cell hyperplasiaLiangwu Sun
The Burnham Institute, Program for Glycobiology and Carbohydrate Chemistry, 10901 North Torrey Pines Road, La Jolla, California 92037, USA
J Clin Endocrinol Metab 90:4371-5. 2005..CONCLUSIONS: Our findings underscore the importance of proper glycosylation in several major organ systems and emphasize that CDG should be ruled out in patients with persistent hyperinsulinemic hypoglycemia of unknown etiology...
Novel carboxylated N-glycans contain oligosaccharide-linked glutamic acidGeetha Srikrishna
Glycobiology Program, The Burnham Institute, La Jolla, CA, USA
Biochem Biophys Res Commun 332:1020-7. 2005..These results demonstrate that mammalian cells synthesize complex-type N-glycans with glutamate linked to their antennae, further expanding their potential for covalent or ionic interactions...
Clinical and molecular characterization of the first adult congenital disorder of glycosylation (CDG) type Ic patientLiangwu Sun
The Burnham Institute, La Jolla, CA 92037, USA
Am J Med Genet A 137:22-6. 2005..However, even in adulthood, this patient shows normal magnetic resonance imaging of the brain...
Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblastsErik A Eklund
The Burnham Institute, La Jolla, CA 92037, USA
Glycobiology 15:1084-93. 2005..These results validate the general concept of using pro-Man-1-P substrates as potential therapeutics for CDG-I patients...
Congenital disorder of glycosylation Ic due to a de novo deletion and an hALG-6 mutationErik A Eklund
Glycobiology and Carbohydrate Chemistry Program, The Burnham Institute, 10901 N Torrey Pines Road, La Jolla, CA 92037, USA
Biochem Biophys Res Commun 339:755-60. 2006..2p32.3)] and found no structural abnormalities in the father, suggesting a de novo event. Our findings extend the causes of CDG to larger DNA deletions and identify the first Japanese CDG-Ic mutation...
Clinical and biochemical characterization of a patient with congenital disorder of glycosylation (CDG) IIxYoshiaki Miura
Burnham Institute, Program for Glycobiology and Carbohydrate Chemistry, La Jolla, Calif 92037, USA
J Pediatr 147:851-3. 2005..Transferrin analysis showed only hyposialylation, but analysis of total serum N-glycans indicated loss of additional sugars, arguing that the latter generates a more informative picture to search for the primary defect...
Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathyLars Bode
Burnham Institute for Medical Research, Glycobiology and Carbohydrate Chemistry Program, La Jolla, California 92037, USA
J Biol Chem 281:7809-15. 2006..Soluble heparin fully compensated for HS loss, providing a reasonable explanation for patient favorable response to heparin therapy...
A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiencyVibeke Westphal
The Burnham Institute, Glycobiology Program, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA
Hum Mol Genet 11:599-604. 2002..We speculate that this type of variant may be implicated in other multi-factorial disorders that involve N-glycosylation...
Research Grants
- Carbohydrate Deficient Glycoprotein Syndromes: Models and TherapyHudson H Freeze; Fiscal Year: 2010..PUBLIC HEALTH RELEVANCE: We will study the first mouse model of a rare human genetic disorder in protein glycosylation, offer a likely therapy, and apply the model/therapy to treat other human glycosylation disorders. ..
- CARBOHYDRATE DEFICIENT GLYCOPROTEIN SYNDROMESHudson Freeze; Fiscal Year: 2003..Analysis of glycosylation-deficient patients will broaden our understanding ob both glycobiology and its immediate application to human glycosylation diseases. ..
- Novel Approaches to Mend Deficient GlycosylationHudson Freeze; Fiscal Year: 2005....
- Basis of Post-Fontan Protein Losing EnteropathyHudson Freeze; Fiscal Year: 2006..The results could provide a fundamental understanding of how PLE develops, identify Fontan patients genetically at risk for developing PLE, and provide insights to new therapeutics for this enigmatic rare disease. ..
- Novel Carboxylated Glycans in Cell AdhesionHudson Freeze; Fiscal Year: 2006....
- CARBOHYDRATE DEFICIENT GLYCOPROTEIN SYNDROMESHudson Freeze; Fiscal Year: 2007..In the long run, we want to understand their physiological and molecular basis of new disorders and provide underpinnings for patient therapy. ..
- Factors Determining Protein Losing EnteropathyHudson H Freeze; Fiscal Year: 2010..We propose to make a mouse model of PLE and test a novel therapy developed in our laboratory. Our long-range goal is to identify at-risk patients and provide a therapy for them. ..
- Human Glycosylation Disorders 2003Hudson Freeze; Fiscal Year: 2004..Since this meeting immediately precedes the annual meeting of the Society for Glycobiology, it will increase the chances of recruiting glycobiologists to explore the various types of human glycosylation disorders. ..
- MANNOSE IN MAMMALIAN GLYCOPROTEIN SYNTHESISHudson Freeze; Fiscal Year: 2001..In some cases, mannose may be a therapeutic dietary supplement. A mannose supplementation trial for CDGS patients is now underway. ..
- Novel Carboxylated N-Glycans that Mediate InflammationHudson Freeze; Fiscal Year: 2003..The impact of solving these structures could be quite substantial. However, in the past, we have had difficulty establishing this structure, and therein lies the risk in this project and why it responds to PA-97-049. ..
